UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000021990
Receipt No. R000025342
Official scientific title of the study Assessment for the postgastrectomy syndrome
Date of disclosure of the study information 2016/04/20
Last modified on 2016/04/19 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Assessment for the postgastrectomy syndrome
Title of the study (Brief title) Assessment for the postgastrectomy syndrome
Region
Japan

Condition
Condition Gastric cancer without distant metastasis
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate general and nutritional condition for the postgastrectomy patients.
Basic objectives2 Others
Basic objectives -Others Observational study
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Post operative Quality of Life. ( One month after, One year after)
Key secondary outcomes Post operative nutritional condition. ( One month after, One year after)

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Histologically proven primary gastric cancer without distant metastasis
Key exclusion criteria Metastasis to distant organ sites, other active concomitant malignancies, or recurrent gastric cancers.
Target sample size 200

Research contact person
Name of lead principal investigator Shigeru Sasaki
Organization Saitama Red Cross Hospital
Division name Department of Surgery
Address 8-3-33, Kamiochiai, Chuo-ku, Saitama city, Saitama
TEL 048-645-1617
Email shsasaki@saitama-med.jrc.or.jp

Public contact
Name of contact person Shigeru Sasaki
Organization Saitama Red Cross Hospital
Division name Department of Surgery
Address 8-3-33, Kamiochiai, Chuo-ku, Saitama city, Saitama
TEL 048-645-1617
Homepage URL
Email shsasaki@saitama-med.jrc.or.jp

Sponsor
Institute Saitama Red Cross Hospital, Department of Surgery
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Saitama Red Cross Hospital, Department of Surgery
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions さいたま赤十字病院(埼玉県)

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 20 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 08 Month 01 Day
Anticipated trial start date
2015 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Clinical stage of gastric cancer, Type of pathological character, Ages, Comorbidity, With or without chemotherapy, Type of operation and reconstruction, Operation time, Complications, PGSAS-45(PGSAS-37 + SF-8), Body Composition Analyze, etc.

Management information
Registered date
2016 Year 04 Month 19 Day
Last modified on
2016 Year 04 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025342